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SUMMARY 
 
Peptide ligation chemistry has revolutionized protein science by facilitating 
access to synthetic proteins. Herein, we describe the development of additive–
free ligation–deselenization chemistry at b-selenoaspartate and g-
selenoglutamate that enables the generation of native polypeptide products on 
unprecedented time scales. The deselenization step is chemoselective in the 
presence of unprotected selenocysteine, which is highlighted in the synthesis of 
selenoprotein K. The power of the methodology is also showcased through the 
synthesis of three tick-derived thrombin-inhibiting proteins, each of which were 
assembled, purified and isolated for biological assays within a few hours.  
 
The Bigger Picture 
Over the past decade there has been a renaissance in the use of large polypeptides 
and proteins as therapeutic agents meaning that there is significant need for 
technologies to rapidly and efficiently access these biomolecules. While biological 
expression systems serve a critical role in the production of polypeptides, these are 
not a ‘one-stop shop’; some targets cannot be produced using recombinant methods 
due to peptide/protein toxicity, and the techniques are often limited to the 
incorporation of the 20 proteinogenic amino acids. The advent of peptide ligation 
technologies, based around the native chemical ligation methodology, have 
revolutionized protein science by providing an avenue to access polypeptides and 
proteins with tailor-made modifications to maximize specificity and activity or to 
probe biological function (e.g. through incorporation of post-translational 
modifications and fluorophores, respectively). One of the key problems remaining in 
the field is that often the time required to assemble a particular protein target is 
unacceptably long. In this article, we describe the development of a one-pot ligation–
deselenization technology at aspartate and glutamate that enables the synthesis of 
native polypeptides and proteins on unprecedented timescales. The key feature of 
	
	
	
the methodology is that both the ligation and deselenization reactions are 
chemoselective, proceed rapidly and cleanly, and are compatible for use in a one-
pot regime. The power of the chemoselective deselenization step is highlighted 
through the synthesis of selenoprotein K, containing a native selenocysteine residue. 
Moreover, the utility of the technology is showcased through the synthesis of three 
small protein targets, which could be assembled and purified within a few hours. The 
methodology described here should serve as a powerful means to access synthetic 
proteins, including therapeutic leads, in the future.      
INTRODUCTION 
Native chemical ligation has revolutionized the field of protein science by facilitating 
access to native, modified and designer biomolecules for interrogative studies on 
structure and/or function.1,2 The need for a cysteine residue (the least abundant 
proteinogenic amino acid) on the N-terminus of one of the reacting peptide 
fragments has motivated the development of b-, g- and d-thiolated variants of other 
amino acids3-14 as well as thiol-containing  auxiliaries that can be employed as Cys 
surrogates in ligation chemistry.15-20 Following ligation reactions at these residues, 
the thiol auxiliary is desulfurized (usually by means of radical-based protocols21) in 
order to obtain native polypeptide products (Scheme 1A). However, this 
transformation is not chemoselective in the presence of other unprotected cysteine 
residues that might be found elsewhere in the sequence. This limitation of 
desulfurization chemistry has led to expansion of the native chemical ligation 
transformation to peptides bearing the 21st amino acid selenocysteine (Sec)22-24 as 
well as selenoamino acids (specifically Pro25 and Phe26 to date). The key advantage 
of carrying out ligation chemistry at ‘selenoamino acids’ rather than ‘thioamino acids’ 
is that chemoselective deselenization can be performed under mild conditions 
(typically a phosphine reductant and a hydrogen-atom source) that do not affect 
unprotected Cys residues.22 It has also been demonstrated independently by us27 and 
Metanis and co-workers28 that ligation products can be subjected to oxidative 
deselenization to afford Ser in place of Sec at the ligation junction. 
 
Scheme 1. A) Native chemical ligation–desulfurization; B) One-pot additive–free diselenide–
selenoester ligation–deselenization reaction at (b-Se)-Asp and (g-Se)-Glu reported here. NB: 
when X = Se, Sec often exists as an intramolecular diselenide with (b-Se)-Asp and (g-Se)-Glu 
before deselenization. 	 
 
While there are clear benefits to using Sec or other selenoamino acids in native 
chemical ligation, the rates of these reactions in the presence of an aryl thiol as a 
reductant are generally slower than would be anticipated based on the significantly 
enhanced nucleophilicity of selenolates (compared with the corresponding thiolates 
used in native chemical ligation). These slow reaction rates can be rationalized by the 
low redox potential of Sec (–381 mV),29 coupled with the weak reductive power of 
aryl thiols, which provides a low steady-state concentration of selenolate during the 
	
	
	
ligation reaction.23 One solution is to employ stronger reducing agents, e.g., a 
phosphine. However, this promotes homolysis of the weak C–Se bond of Sec, a 
transformation that has been exploited for the chemoselective deselenization of Sec 
to Ala in the presence of free Cys (vide supra).22,30 Metanis and co-workers have 
recently reported a workable solution to this deleterious side reaction at Sec via the 
use of TCEP in the presence of ascorbate as a radical trap.31 However, this approach 
prevents in situ deselenization chemistry without prior removal of ascorbate from the 
reaction mixture.  
 
We have recently reported that peptides possessing an N-terminal selenocystine 
moiety (the oxidized form of Sec) can be ligated to peptides bearing a C-terminal 
aryl selenoester in aqueous buffer without the use of any additives in the reaction.32 
These ligation reactions were demonstrated to have unparalleled reaction rates (1 – 
10 min) compared with the corresponding thiol-mediated ligation reactions (1 h – > 
48 h) and could be coupled with in situ radical deselenization (through the addition 
of TCEP and DTT) to afford native peptide products in excellent yields. Whilst this 
new additive–free methodology provides a significant advance in ligation 
technology, a synthetic bottleneck still exists in the deselenization step, which 
typically requires 6-16 h to reach completion. Clearly, enhancing the rate of the 
deselenization step would raise the possibility of generating native polypeptides and 
proteins on unprecedented timescales. Herein we demonstrate that peptides 
possessing N-terminal b-selenoaspartate [(b-Se)-Asp] or g-selenoglutamate [(g-Se)-
Glu] residues can facilitate rapid and efficient additive–free ligation reactions with 
peptide selenoesters (Scheme 1B). Crucially, these ligations can be coupled with 
one-pot deselenization reactions that proceed cleanly in under a minute. The rapid 
nature of both the additive–free ligation and deselenization reactions at Asp and Glu 
enables the preparation of proteins in minutes, a feature which we highlight through 
the synthesis of three tick-derived protein thrombin inhibitors.  
 
RESULTS  
 
Synthesis of b-selenoaspartate and g-selenoglutamate building blocks and 
incorporation into peptides 
The synthesis of a suitably protected (b-Se)-Asp building block began with 
electrophilic selenylation chemistry, analogous to the sulfenylation transformation we 
recently reported in the synthesis of thioamino acids.4,13,14 Initially, our intention was 
to incorporate a 2,4,6-trimethoxybenzyl (Tmb)-protected selenol unit into the target 
amino acid. However, the instability of the Tmb-protected selenosulfonate precluded 
isolation. We next investigated the preparation of a less electron-rich selenylating 
reagent, namely, p-methoxybenzyl (PMB) selenosulfonate 1. This reagent was 
prepared by treatment of diselenide 2 with AgNO3 in the presence of sodium 
benzenesulfinate (Scheme 2A and Figures S103-S106). Selenylation was next 
effected through the addition of selenosulfonate 1 to the dianion of orthogonally-
protected Asp 3 at low temperature and provided b-Se amino acid 4 in 81% yield as 
an 85:15 (syn:anti) mixture of diastereomers (inseparable by flash column 
chromatography but separable by C18 reverse-phase HPLC, vide infra, Scheme 2B). 
Finally, allyl ester deprotection was facilitated by treatment with 
(tetrakis)triphenylphosphine palladium (0) and phenylsilane to afford the desired 
building block 5 (85:15 syn:anti) in excellent yield (Figures S107-S110). Similarly, 
suitably protected (g-Se)-Glu building block 6 could be prepared by selenylation of 
Boc-Glu(OtBu)-OAll 7 followed by allyl ester deprotection in excellent yield (Scheme 
2C). On this occasion 6 was prepared as a single diastereoisomer (2S, 4S as 
determined by NMR spectroscopy) due to the exquisite stereoselectivity of the 
selenylation reaction on the Glu substrate (Figures S111-S114). 
	
	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. Synthesis of A) selenylating reagent 1; B) PMB-protected b-selenyl aspartate 5, and C) 
PMB-protected g-selenyl glutamate 6 
 
The protected selenylated aspartate building block 5 was next incorporated into the 
N-terminus of a model peptide using Fmoc-strategy SPPS to afford resin-bound 9 
(see Scheme 3A and Supplemental Information). Following acidolytic side-chain 
deprotection/cleavage from the resin, oxidative deprotection of the PMB 
selenoether protecting group (20% DMSO in TFA) and purification by reverse-phase 
HPLC, the peptide diselenide dimer 10 was isolated in 44% yield based on the 
original resin loading. It should be noted that the acidity of the b-proton of 5 led to 
epimerization during coupling to afford a 1:1 (syn:anti) mixture of diastereomers of 
the final peptide product 10 (Figures S1 and S2). This was inconsequential to the 
purity of the final product as the stereocenter is destined for removal through 
deselenization after the ligation event (Figure S3). We also demonstrated that the 
nature of the stereochemistry at the b-center does not lead to significant differences 
in ligation rate. Specifically, when HPLC-separated syn and anti diastereomers of 4 
(Scheme 2B) were deprotected and subjected to an additive–free diselenide–
selenoester ligation reaction, both reached completion at similar time points (see 
Supplemental Information for details). Selenylated glutamate 6 could also be 
coupled to the N-terminus of a resin-bound peptide to afford 11 followed by 
acidolytic deprotection and cleavage from the resin (Scheme 3B). On this occasion 
PMB-deprotection was best effected by DTNP (5.2 eq.) in TFA to afford the 
corresponding selenyl sulfide which could be removed by treatment with a solution 
of 40 mM ascorbate in phosphate buffer to provide the desired peptide target in 
36% yield based on the original resin loading (Figure S4). In contrast to 
selenopeptide 10, 12 was produced as a single diastereomer (Figure S5). 
 
 
Scheme 3. Synthesis of model peptides A) 10 bearing an N-terminal (b-Se)-Asp and B) 12 bearing 
an N-terminal (g-Se)-Glu.      
 
One-pot additive–free diselenide–selenoester ligation–deselenization reactions 
at (b-Se)-Asp and (g-Se)-Glu 
With model diselenide dimer peptides 10 and 12 in hand, we next explored 
additive–free ligation reactions with a range of model selenoesters (13–19). 
Specifically, 10 or 12 and a given peptide selenoester (see Supplementary 
	
	
	
Information for selenoester synthesis and Figures S6-S12 for characterization data) 
were simply dissolved in 6 M Gdn•HCl, 0.1 M phosphate buffer, at a final pH of 6.2–
6.5 (with no additives or pH adjustment necessary). Gratifyingly, all reactions 
proceeded cleanly to afford the desired ligation products in excellent yield as judged 
by UPLC-MS analysis. As reported in our prior investigations on the selenocystine–
selenoester ligation,32 multiple products are observed from the ligation reaction 
(denoted as I–III for ligation at (b-Se)-Asp in Table 1). While symmetric diselenide I is 
usually observed as the major product, together with a small amount (<10%) of 
asymmetric diselenide product II, product selenoester III is observed when an excess 
of the selenoester fragment is used in the reaction and/or when selenoesters bearing 
sterically hindered C-terminal residues, e.g. Val and Leu, are employed. However, 
the ratio of these products is inconsequential for the overall efficiency of the reaction 
as these converge into the single native polypeptide product following 
deselenization. The rates of the additive–free diselenide–selenoester ligation 
reactions at both (b-Se)-Asp and (g-Se)-Glu were rapid, with all reactions reaching 
completion between 5 and 55 min [as judged by UPLC-MS analysis and by 
precipitation of diphenyldiselenide (DPDS) – a visual prompt for completion of the 
reactions]. Notably, ligations at selenoesters bearing C-terminal Ala (13), Ser (14), 
Phe (15), Tyr (16), Met (17) and Leu (18) were complete between 5–15 min, 
significantly faster than native chemical ligation at Cys and the homologous b-
mercapto-Asp4 and g-mercapto-Glu.14 Furthermore, ligation with selenoester 19 with 
a sterically hindered C-terminal Val residue was complete in 55 minutes at Asp and 
45 min at Glu, again significantly faster than the thiolate equivalents (b-mercapto-
Asp4 and g-mercapto-Glu14; 16 h). 
 
Upon completion of the additive–free ligations, crude reaction mixtures were 
subjected to in situ deselenization. This involved extraction of the precipitated DPDS 
with hexane, followed by treatment with TCEP (50 eq.) and DTT (5 eq.). Remarkably, 
the deselenization of (b-Se)-Asp and (g-Se)-Glu proceeded cleanly and to completion 
(in all cases) within 60 seconds, cf. deselenization at Sec that requires 4–6 hours (see 
Figures S13-S40 for data). Interestingly, the deselenization was also complete within 
a minute at a wide (1.8–7.0) pH range (see Figures S54–S58). The resulting products 
from the one-pot additive–free diselenide–selenoester ligation–deselenization 
reactions were subsequently purified by reverse–phase HPLC to afford the native 
peptide products 20–26 (for ligations at (b-Se)-Asp) and 27–33 for ligations at (g-Se)-
Glu in excellent yield (52–91%) over the two steps (Table 1 and Figures S13-S40). 
Importantly, the exceptional rates of the additive–free ligation and deselenization 
reactions at (b-Se)-Asp and (g-Se)-Glu enable access to native peptides in minutes 
(including at sterically hindered junctions), a timescale that, to our knowledge, cannot 
be achieved with currently available techniques.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
	
Table 1. Scope of the one–pot additive–free diselenide–selenoester ligation–deselenization at 
(b-Se)-Asp and (g-Se)-Glu. 
 
 
 
Entry Peptide 
diselenide 
Selenoester 
(X) 
Ligation 
Time (min) 
 Yield for One-
Pot Ligation–
Deselenization 
    
1 10 13: X = A 5 a  20: 64% 
2 10 14: X = S 10 a  21: 57% 
3 10 15: X = F 10 a  22: 53% 
4 10 16: X = Y 5 a  23: 64% 
5 10 17: X = M 5 a  24: 65% 
6 10 18: X = L 15 a  25: 72% 
7 10 19: X = V 55b  26: 58% 
8 12 13: X = A 10 a  27: 77% 
9 12 14: X = S 10 a  28: 76% 
10 12 15: X = F 10 a  29: 91% 
11 12 16: X = Y 15 a  30: 60% 
12 12 17: X = M 15 a  31: 67% 
13 12 18: X = L 10 a  32: 67% 
14 12 19: X = V 45b  33: 52% 
Conditions: Additive-free ligation; 2.5 mM final concentration of diselenide dimer in 6 M Gdn•HCl, 0.1 
M Na2HPO4, pH 7.2 (reduces to 6.2-6.5 upon addition to peptide fragments). One–pot deselenization; 
hexane extraction (x5) followed by addition of 0.25 M TCEP, 25 mM DTT in 6 M Gdn•HCl, 0.1 M Na2HPO4, 
pH 5 – 6.  
a 0.5 eq. of H-(β-Se)DSPGYS-NH2 dimer or H-(g-Se)ESPGYS-NH2 dimer to 1.3 eq. of selenoester.  
b 0.5 eq. of H-(β-Se)DSPGYS-NH2 dimer or H-(g-Se)ESPGYS-NH2 dimer to 2.0 eq. of selenoester. 
NB: products from the additive-free ligation at β-Se-Asp I-III (not isolated) shown in box.  
 
Ligation–deselenization using additives 
Very recently it has been reported that native chemical ligation reactions at Sec 
(using peptide thioesters as the acyl donor) can be performed in the presence of the 
reductant TCEP (that normally facilitates deselenization) through the addition of 
ascorbic acid.31 We were therefore interested to assess whether (b-Se)-Asp could be 
employed in “additive ligations” through a native chemical ligation pathway. To this 
end, we reacted 10 with peptide selenoester 19 in the presence of 50 mM TCEP and 
100 mM ascorbic acid in ligation buffer.31 Unfortunately, these conditions resulted in 
complete deselenization of starting diselenide dimer peptide 10 with no detectable 
ligation product (Figures S41 and S42). Given that these conditions prevent 
deselenization of Sec-containing peptides (see31 and Figures S43 and S44), this 
observation reflects the increased lability of the C–Se bond in the b-Se Asp moiety 
(vide supra). We therefore sought to optimize additive conditions using an alternative 
radical trap, namely diphenyldiselenide (DPDS), in place of ascorbic acid. Optimized 
conditions involved ligation between 10 and 19 at a saturating concentration of 
DPDS (250 mM) and 25 mM TCEP (Figures S45-47). While a significant amount of the 
desired product was formed (in deselenized form), deselenization of starting peptide 
10 could not be prevented entirely, thus lowering the overall yield of the reaction.  
 
	
	
	
Mechanistic insight into the rapid deselenization reaction 
Having established that ligation reactions at (b-Se)-Asp and (g-Se)-Glu must be strictly 
performed under an additive–free regime, we moved to further explore the 
exceptional rate enhancement observed for deselenization at these amino acids 
compared with Sec (see Supplemental Information). The current mechanistic model 
for deselenization using a phosphine, e.g. TCEP, and a hydrogen-atom source, e.g. 
DTT, invokes an initial reduction of the diselenide (or selenyl sulfide for native 
chemical ligation) to afford a selenol (see A, Scheme 4), which could serve as a 
precursor to a small amount of Se-centered radical B.22,28 It is also feasible that B 
could be generated from the starting diselenide.33 Regardless of the pathway to the 
selenium-centered radical, B could react rapidly with the phosphine to generate the 
phosphorus-centered radical species C. C–Se bond homolysis of C would generate 
a β-carbon-centered radical D and phosphine selenide E (proposed to be a key 
driving force for the reaction). Hydrogen-atom abstraction by the b-carbon centered 
radical D could then produce the native amino acid F. Interestingly, we have 
demonstrated that deselenization reactions proceed to completion (and at similar 
rates) at (b-Se)-Asp even in the absence of an H-atom source such as DTT (Figure 
S59). This suggests that the H-atom abstraction may be possible from selenol A 
(produced by TCEP reduction of the starting diselenide) that would regenerate B 
and propagate a radical chain as depicted in Scheme 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. Putative pathways for the deselenization of selenoamino acids. For TCEP, R = 
CH2CH2CO2- 
 
To help understand the significant rate enhancement observed for deselenization, 
initially at (b-Se)-Asp, we probed the energies associated with the formation of the 
proposed intermediates with computational quantum chemistry calculations. These 
were performed with the Gaussian 09 program,34 using the species depicted in 
Scheme 4 as models (Table S1). Gas-phase energies were obtained at the DSD-
PBEP86/aug’-cc-pVTZ level,35 with the effect of solvation incorporated through the 
SMD continuum model at the M05-2X/6-31G(d) level. Our calculated energies 
corresponding to the individual steps for the pathways shown in Scheme 4, together 
with a schematic energy profile are included in the Supplemental Information (Tables 
S1 and S2 and Figure S115). Thus, the barrier calculated for C → D for the 
unsubstituted system (X = H) is 23.4 kJ mol–1 whereas that for the aspartate derivative 
(X = CO2–) is –5.3 kJ mol–1, the negative value indicating that this modification 
essentially removes the barrier (Table S1 and Figure S115). This is owing to 
stabilization of the electron-deficient radical center by the anionic b-carboxylate 
moiety. Corresponding calculated spin densities for species involved in the 
conversion of C to D are consistent with the energy data (Figure S116). In addition, 
abstraction of the H atom from DTT by carbon-centered radical D is predicted to 
have a lower barrier of 5.3 kJ mol–1 for (b-Se)-Asp (X = CO2–) compared with Sec (X = 
H, 10.9 kJ mol–1). We performed the analogous computational experiments for the 
	
	
	
proposed pathway in Scheme 4 with (g-Se)-Glu (Tables S1 and S2 and Figure S115). 
Perhaps unsurprisingly, the key barrier for cleavage of the C–Se bond in TCEP adduct 
C to afford carbon-centered radical D was very similar to that calculated for the Asp 
homologue (Table S1 and Figure S115), which agrees with our experimental 
observation, i.e. that deselenization at both (b-Se)-Asp and (g-Se)-Glu are rapid.  
 
Selectivity of deselenization 
Given the expedient nature of the deselenization step, we were interested in probing 
whether selective deselenization of (b-Se)-Asp and (g-Se)-Glu would be possible 
without concomitant conversion of Sec to Ala. Towards this end, we first 
demonstrated that (b-Se)-Asp and (g-Se)-Glu could be selectively deselenized in a 
model peptide that also possessed an unprotected Sec (Figures S48–S53). Having 
demonstrated the chemoselectivity on a model system, we next embarked on the 
assembly of a protein target that would benefit from the chemoselective 
deselenization transformation. For this purpose, we chose the 93 amino acid protein 
selenoprotein K (SelK) 34 (residues 2-94), possessing a Sec residue at position 92 
that cannot be used to assemble the protein via ligation due to its C-terminal 
proximity. Unlike most selenoproteins that possess selenosulfide linkages, SelK exists 
as a homodimer linked via an intermolecular diselenide at Sec92.36 While the exact 
biological role of SelK has not been established, Sec92 and the high redox potential 
of the intermolecular diselenide bond is thought to be important for protein 
function.37 Assembly of peptide selenoester 35 and peptide 36 bearing an N-
terminal (b-Se)-Asp and an internal Sec residue (linked as an intramolecular 
diselenide) was first performed using Fmoc-SPPS methods (Scheme 5, 
Supplementary Information and Figures S60-S63). Peptide 36 was prepared with two 
norleucines substituted for methionine (Met) residues owing to significant but 
incomplete oxidation of the thioether side chains of Met during the acidic 
deprotection and cleavage conditions of the peptide fragments that complicated 
analysis. Ligation under the additive–free conditions was performed by simply 
dissolving the two fragments in aqueous ligation buffer (adjusted to pH 6.0) using a 
two-fold excess of selenoester 35. Following 15 min the reaction had proceeded to 
completion to afford a mixture of intramolecular diselenide 37 and the selenoester-
linked ligation product, as judged by UPLC-MS analysis. Following hydrazinolysis of 
the unproductive selenoesters, 37 was afforded as the exclusive ligation product 
(Figure S64). The intramolecular diselenide ligation product 37 was subsequently 
isolated in 62% yield following reverse-phase HPLC (Figures S65 and S66). 
Gratifyingly, treatment of 37 with TCEP, in the absence of DTT, for 2 min led to 
chemoselective deselenization of the (b-Se)-Asp without any observed Sec 
deselenization. Purification subsequently afforded SelK 34 in 84% yield (Figure S67). 
Mass spectrometric analysis confirmed that 34 was isolated as the homodimer with  
a molecular weight of 21 kDa (Figure S68).38 Having successfully showcased the 
chemoselective deselenization in the synthesis of SelK with intermediary purification, 
we next attempted to rapidly access the selenoprotein using a one-pot protocol 
(Scheme 5A). Towards this end, rapid additive–free ligation between 35 and 36, 
followed by in situ hydrazine treatment and chemoselective deselenization via 
treatment with TCEP provided SelK together with the acyl hydrazide of selenoester 
fragment 35 (Figure S69). Following reverse-phase HPLC purification, homodimeric 
SelK 34 was isolated in 40% yield and in excellent purity over the three synthetic 
steps (Scheme  5B and 5C and Figures  S70 and S71).  
 
	
	
	
				
 
 
 
 
 
 
 
 
 
 
Scheme 5. A) Synthesis of homodimeric SelK via additive–free diselenide–selenoester ligation at 
(b-Se)-Asp followed by chemoselective deselenization in the presence of native and unprotected 
Sec92 ; B) HPLC trace of purified synthetic SelK following one–pot ligation–deselenization 
protocol, rt = 26.6 min, l = 220 nm; C) ESI mass spectrum of synthetic SelK homodimer 34. 
 
 
One-pot synthesis of the hyalomins via ligation–deselenization  
In our previously described selenocystine–selenoester ligation,32 the deselenization 
of Sec was the synthetic bottleneck, requiring 4–6 h to reach completion. As such, 
this step prevented full exploitation of the exceptional rate of the additive–free 
ligation reaction. We envisaged that the increase in deselenization rate at (b-Se)-Asp, 
coupled with the fast additive–free ligation rates at this residue, would provide a 
unique means to access target proteins by chemical synthesis within hours rather 
than days, a feature that was showcased in the synthesis of SelK. To investigate this 
possibility further, we sought to prepare a selection of small thrombin-inhibiting 
hyalomin proteins (hyalomin-2, hyalomin-3 and hyalomin-4) using our methodology. 
The hyalomins are a family of four cysteine-free proteins produced within the salivary 
glands of the tick Hyalomma marginatum rufipes that support the blood-feeding 
activity of the organism.39 The absence of Ala residues at a site that would permit 
assembly through other ligation approaches, together with the wealth of acidic 
residues within the sequences (pI < 4), made these amenable to assembly using our 
ligation technology. Disconnection of hyalomins 2–4 (38–40) was made at Asp 
residues close to the middle of the sequences. The C-terminal diselenide dimer 
peptide fragments 41–43 were synthesized on 2-chlorotrityl chloride resin via Fmoc-
SPPS with the incorporation of (b-Se)-Asp building block 5 at the N-terminus (Figures 
S72-S77). N-terminal peptides were also prepared on 2-chlorotrityl chloride resin via 
Fmoc-SPPS and converted to C-terminal phenylselenoesters 44–46 (Figures S78-
S83).  
B) C) 
	
	
	
 
 
With the requisite fragments in hand, we next set out to prepare each of the hyalomin 
targets with an emphasis on synthesis, purification and isolation within a short 
timeframe. Towards this end, diselenide dimer fragments 41–43 (1 eq. based on the 
monomeric peptide) were reacted with peptide selenoesters 44–46 (1.5 eq. and 1.6 
eq. for 44 and 46 respectively and 2 eq. for 45) in ligation buffer (pH adjusted to 6.2) 
under additive–free conditions (Scheme 6). Gratifyingly, the reactions proceeded in 
just 2 mins to afford the desired ligation products as a mixture of the symmetrical 
diselenide dimer and product bearing a selenoester linkage (as judged by UPLC-MS 
analysis). Subsequent deselenization was effected via addition of TCEP (50 eq.) and 
Scheme 6. Synthesis of thrombin-inhibiting proteins A) hyalomin-2, B) hyalomin-3 and C) 
hyalomin-4 via one-pot additive-free diselenide–selenoester ligation at (b-Se)-Asp. All products 
were synthesized, purified, characterized and quantified within a 3 h time period; D) crude HPLC 
of one-pot ligation–deselenization to afford hyalomin-2 (38), rt = 23.5 min, l = 280 nm; E) HPLC 
of purified hyalomin-2 (38), rt = 23.5 min, l = 280 nm; F) ESI-mass spectrum of hyalomin-2 (38). 
* Hyalomin-2 was produced with Met18 oxidized. The sulfoxide could be reduced in a 
subsequent step to afford the native protein in 96% yield (see Supplemental Information for 
details). 
	
	
	
DTT (5 eq.) and, like the model systems, proceeded smoothly and to completion 
within 1 min (Figure S84, S89 and S94). It should be noted that the DTT was added 
to the reaction to thiolyze the product selenoester to the corresponding selenol, 
which could be subsequently deselenized with TCEP. The crude hyalomins were 
purified by RP-HPLC over a 30 min gradient, and fractions containing the desired 
protein were analysed using a UPLC-MS system with a gradient of 3 min, thus 
allowing numerous samples to be run over a short period. The relevant fractions were 
pooled and the solvent removed on a Genevac solvent evaporation system over 1 h 
at 50 °C and 3 mbar. The pure proteins were re-dissolved in distilled water and the 
concentration confirmed by NanoDrop UV-Vis to determine concentrations of the 
protein solutions (for direct use in thrombin inhibitory assays). Following the one–pot 
diselenide–selenoester ligation–deselenization and purification, the hyalomins were 
isolated in excellent yields (65–67%). Importantly, following ligation of the peptide 
fragments, purification, characterization, solvent removal and quantification of the 
pure proteins, each of the hyalomins were generated within an impressively brief 3 h 
period in >98% purity (Figures S84-S98). Finally, having accessed hyalomins 2–4 (38–
40) we next assessed the activity of the synthetic proteins as inhibitors of human 
thrombin (see Supplemental Information for details). Both hyalomin 2 (38) and 
hyalomin 3 (39) proved to be extremely potent thrombin inhibitors with inhibition 
constants (Ki) of 1.24 ± 0.05 nM and 14.73 ± 0.64 nM, respectively (Figures S99-
S102). Surprisingly, hyalomin-4 (40) exhibited weaker inhibitory activity (IC50 = 20 
µM), possibly owing to the significantly shorter C-terminal tail region of this protein 
compared with 38 and 39. Future work in our laboratories will focus on determining 
the three-dimensional structure of thrombin-hyalomin complexes to elucidate their 
inhibitory binding mode. 
 
Conclusions 
In summary, we have developed a short and efficient synthesis of suitably protected 
(b-Se)-Asp and (g-Se)-Glu building blocks. We have demonstrated that these 
selenylated amino acids can be incorporated into resin-bound peptides and facilitate 
rapid, additive–free ligation reactions with peptide selenoesters. Following the 
ligation event, and without purification, deselenization of the b- and g-seleno 
auxiliaries was smoothly effected within 1 min in all cases. The impressive rates of 
deselenization at (b-Se)-Asp were highlighted in the synthesis of SelK, whereby the 
b-seleno auxiliary on Asp could be chemoselectively deselenized in the presence of 
Sec to afford the native selenoprotein. Furthermore, the rapid rates of both the 
ligation and deselenization steps were showcased in the one–pot assembly of three 
thrombin inhibitory proteins from the hyalomin family, which could all be assembled, 
purified and isolated within 3 h for immediate assessment in thrombin inhibition 
assays. The simplicity, efficiency and speed of the ligation–deselenization chemistry 
described here should see the technology applied to the synthesis of numerous 
protein targets and protein libraries. 
 
EXPERIMENTAL PROCEDURES 
General procedure for one-pot additive–free diselenide–selenoester ligation–
deselenization 
The diselenide dimer peptide 10 [H-(β-Se)DSPGYS-NH2] (2.0 mg, 1.4 μmol) or 12 [H-
(g-Se)ESPGYS-NH2] (1.0 mg, 0.7 μmol) and a selenoester Ac-LYRANX-SePh (13-19) 
(3.6 μmol for reaction with 10 or 1.8 μmol for reaction with 12) were separately 
dissolved in ligation buffer (6 M Gdn•HCl, 0.1 M Na2HPO4, pH = 7.1) to a 
 
	
	
	
concentration of 10 mM (with respect to the selenopeptide fragment) and 13 mM 
(with respect to the selenoester fragment or 20 mM in the examples with Ac-
LYRANV-SePh). The selenoester solution was added in one portion to the solution of 
diselenide in an Eppendorf tube and the reaction mixture left at rt with intermittent 
agitation. Analytical HPLC-MS analysis indicated consumption of the diselenide and 
formation of ligation products at the times indicated in Table 1. The ligation reaction 
mixture was washed with an equal volume of hexane (×5) to remove 
diphenyldiselenide (DPDS) and sparged with nitrogen for 5–10 min. Separately a 
solution of TCEP (0.25 M) and DTT (25 mM) was prepared in ligation buffer and the 
pH adjusted to 5 – 6. An equal volume of the TCEP/DTT solution was added in one 
portion to the ligation reaction mixture and the reaction left for 5 min (after 1 min 
HPLC-MS analysis indicated that the ligation products had already been consumed 
and the deselenized peptide had been formed). The reaction mixture was diluted 
with water containing 0.1% TFA, purified by preparative HPLC and lyophilized to give 
the native peptide product as a white solid (see Supplemental Information for UPLC 
data of crude reactions and characterization data of purified peptide products). 
 
SUPPLEMENTAL INFORMATION 
Supplemental Information includes experimental procedures, crude reaction traces 
and characterization data for all novel compounds and thrombin inhibitory data. The 
file includes 101 supplemental figures and geometries for computational studies.  
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